A HERITAGE OF INNOVATION AND LEADERSHIP
Lantheus Medical Imaging, a global leader in developing, manufacturing, selling, and distributing innovative diagnostic imaging agents, is dedicated to creating and providing medical imaging solutions to improve the treatment of human disease.
Our expertise in discovering, developing and commercializing innovative medical imaging agents provides a strong platform from which to bring forward breakthrough tools for the diagnosis and management of disease. Lantheus has a rich heritage and expertise in cardiovascular imaging and nuclear medicine, having pioneered many of the most significant products used in medical imaging.
Our current imaging agents primarily assist in the diagnosis of heart, vascular and other diseases using nuclear imaging, echocardiography and magnetic resonance imaging (MRI) technologies. We have a pipeline of next-generation and first-in-class products using Positron Emission Tomography (PET) and MRI technologies.
Our vision is to be the leading provider of innovative medical imaging solutions to improve human life. We are committed to developing next generation and first-in-class imaging agents to assist physicians in the diagnosis of heart, vascular and other diseases.
With direct operations in the United States, Puerto Rico, Canada and Australia, we have a long and distinguished history of developing and commercializing innovative market-changing products.
Lantheus Medical Imaging Reports Results
for Second Quarter Ended June 30, 2014
Worldwide revenues increase 7% as-reported and 8% constant currency
Adjusted EBITDA increases to $16.3 million on continued gross margin expansion and operating expense leverage
No. BILLERICA, Mass. (August 12, 2014) – Lantheus Medical Imaging, Inc. (“LMI”), a wholly-owned operating subsidiary of parent company Lantheus MI Intermediate, Inc. and a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, today reported financial results for its second quarter ended June 30, 2014.
click here for the press release
Q2 2014 Lantheus Medical Earnings Conference Call
Tuesday, August 12, 2014 at 4:30 p.m. ET